Search Results 141-150 of 16772 for Imiglucerase

  1. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...

  2. Ixekizumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Ixekizumab injection is used to treat moderate-to-severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  3. Lovotibeglogene autotemcel (intravenous route) - Side effects & uses - Mayo Clinic

    Lovotibeglogene autotemcel injection is a one-time gene therapy used to treat sickle cell disease (red blood cell disease) in patients who have a history of ...

  4. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study assess the current patient practice (standard of care) on Health Related Quality of Life (HRQOL), perceived stress level and disease ...

  5. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

    The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory gastric/ ...

  6. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  7. Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections - Mayo Clinic

    The purpose of this study is to look at safety and patient comfort during eye injections. Specifically, it will look to see if an experience is improved with ...

  8. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ibrutinib may stop the growth of tumor cells by ...

  9. AMZ002 Compared to Vigabatrin - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of AMZ002, compared to vigabatrin, in the treatment of infantle spasms (IS). Participation ...

  10. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    About this study. RATIONALE: Drugs used in chemotherapy, such as bendamustine hydrochloride, work in different ways to stop the growth of cancer cells, ...